University of Alabama at Birmingham: Lung Neoplasms trials
The registry lists 13 Lung Neoplasms studies with University of Alabama at Birmingham as lead sponsor. 0 are open to participants now and 4 have results posted.
Phase 1 9Phase 2 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung CancerCompletedNCT01438307Phase 2Results posted
- Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00856830Phase 1/2Results posted
- Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung CancerCompletedNCT00655850Phase 2Results posted
- Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)CompletedNCT00240097Phase 2Results posted
- A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung CancerCompletedNCT02429843Phase 1
- Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung CancerCompletedNCT01004731Phase 1/2
- Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung CancerCompletedNCT00476216Phase 1
- Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00062270Phase 1/2
- CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00033384Phase 2
- Vaccine Therapy in Treating Patients With Metastatic or Recurrent CancerWithdrawnNCT00017537Phase 1
- Combination Chemotherapy in Treating Patients With Small Cell Lung CancerCompletedNCT00004186Phase 1/2
- Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically RemovedCompletedNCT00004160Phase 1/2
- Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid TumorTerminatedNCT00004159Phase 1/2